Stereotaxis (STXS)
(Delayed Data from AMEX)
$2.29 USD
0.00 (0.00%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $2.28 -0.01 (-0.44%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Price, Consensus and EPS Surprise
STXS 2.29 0.00(0.00%)
Will STXS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for STXS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STXS
Stereotaxis (STXS) Achieves CE Mark in Europe for GenesisX
Stereotaxis (STXS) Receives European Approval for GenesisX
STXS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
AxoGen (AXGN) Q2 Earnings and Revenues Beat Estimates
Masimo (MASI) Tops Q2 Earnings and Revenue Estimates
Other News for STXS
Stereotaxis Receives CE Mark For GenesisX, Nears MAGiC Approval
Stereotaxis participates in a conference call with Lake Street
Stereotaxis Inc (STXS) Q2 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...
Wall Street Analysts Are Bullish on Top Healthcare Picks
3 Best Stocks to Buy Now, 8/13/2024, According to Top Analysts